These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 27874994

  • 1. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
    Bérard A, Sheehy O, Zhao JP, Vinet É, Bernatsky S, Abrahamowicz M.
    Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.
    Andrade SE, McPhillips H, Loren D, Raebel MA, Lane K, Livingston J, Boudreau DM, Smith DH, Davis RL, Willy ME, Platt R.
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):246-52. PubMed ID: 19148882
    [Abstract] [Full Text] [Related]

  • 13. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC, Saccone G, Berghella V.
    BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
    [Abstract] [Full Text] [Related]

  • 14. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
    Anderson KN, Lind JN, Simeone RM, Bobo WV, Mitchell AA, Riehle-Colarusso T, Polen KN, Reefhuis J.
    JAMA Psychiatry; 2020 Dec 01; 77(12):1246-1255. PubMed ID: 32777011
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Alwan S, Bandoli G, Chambers CD.
    Clin Pharmacol Ther; 2016 Jul 01; 100(1):34-41. PubMed ID: 27060574
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D, Burns A, Tallon D, Lewis G, MacNeill S, Round J, Hollingworth W, Chew-Graham C, Anderson I, Campbell J, Dickens C, Macleod U, Gilbody S, Davies S, Peters TJ, Wiles N.
    Health Technol Assess; 2018 Nov 01; 22(63):1-136. PubMed ID: 30468145
    [Abstract] [Full Text] [Related]

  • 19. Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors.
    Wilson KL, Zelig CM, Harvey JP, Cunningham BS, Dolinsky BM, Napolitano PG.
    Am J Perinatol; 2011 Jan 01; 28(1):19-24. PubMed ID: 20607643
    [Abstract] [Full Text] [Related]

  • 20. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study.
    Lupattelli A, Spigset O, Koren G, Nordeng H.
    J Clin Psychopharmacol; 2014 Feb 01; 34(1):143-8. PubMed ID: 24135843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.